Jonathan F Foster's most recent trade in Moleculin Biotech Inc was a trade of 810,810 Series E Warrants done . Disclosure was reported to the exchange on June 20, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.00 per share. | 20 Jun 2025 | 810,810 | 1,038,320 | - | - | Series E Warrants | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.37 per share. | 20 Jun 2025 | 270,270 | 287,587 (0%) | 0% | 0.4 | 100,000 | Common Stock |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2025 | 4,328 | 18,371 (0%) | 0% | - | Common Stock | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2025 | 4,328 | 227,510 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2025 | 2,711 | 231,838 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2025 | 2,711 | 14,704 (0%) | 0% | - | Common Stock | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.27 per share. | 20 Jun 2025 | 1,054 | 17,317 (0%) | 0% | 0.3 | 281 | Common Stock |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.27 per share. | 20 Jun 2025 | 661 | 14,043 (0%) | 0% | 0.3 | 176 | Common Stock |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2025 | 833 | 12,196 (0%) | 0% | - | Common Stock | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2025 | 833 | 230,684 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.68 per share. | 16 Jun 2025 | 203 | 11,993 (0%) | 0% | 0.7 | 139 | Common Stock |
| Lear Corp. | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2025 | 1,859 | 1,859 | - | - | Restricted Stock Units | |
| Lear Corp. | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 1,337 | 0 | - | - | Restricted Stock Units | |
| Lear Corp. | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2025 | 1,337 | 13,782 (0%) | 0% | 0 | Common Stock | |
| Five Point Holdings LLC - ... | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Mar 2025 | 14,869 | 135,679 (0%) | 0% | 0 | Class A common shares | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Nov 2024 | 2,092 | 2,092 | - | - | Restricted Stock Units | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 26.38 per share. | 20 Nov 2024 | 15,260 | 31,002 (0%) | 0% | 26.4 | 402,559 | Common Stock |
| Berry Global Group Inc | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2024 | 15,260 | 64,565 | - | - | Director Stock Option (Right to Buy) | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 70.93 per share. | 20 Nov 2024 | 5,676 | 25,326 (0%) | 0% | 70.9 | 402,599 | Common Stock |
| Berry Global Group Inc | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2024 | 1,518 | 15,742 (0%) | 0% | - | Common Stock | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Nov 2024 | 1,518 | 0 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 82,500 | 212,337 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 65,000 | 129,837 | - | - | Stock option (right to buy) | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Oct 2024 | 19,180 | 231,517 | - | - | Performance Based Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2024 | 4,329 | 12,416 (0%) | 0% | - | Common Stock | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Jun 2024 | 4,329 | 64,837 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.74 per share. | 22 Jun 2024 | 1,053 | 11,363 (0%) | 0% | 3.7 | 3,938 | Common Stock |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 2,712 | 69,166 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 Jun 2024 | 2,712 | 8,723 (0%) | 0% | - | Common Stock | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 3.78 per share. | 20 Jun 2024 | 636 | 8,087 (0%) | 0% | 3.8 | 2,404 | Common Stock |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 834 | 6,207 (0%) | 0% | - | Common Stock | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2024 | 834 | 71,878 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 4.14 per share. | 16 Jun 2024 | 196 | 6,011 (0%) | 0% | 4.1 | 811 | Common Stock |
| Lear Corp. | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2024 | 1,419 | 0 | - | - | Restricted Stock Units | |
| Lear Corp. | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 May 2024 | 1,419 | 12,445 (0%) | 0% | 0 | Common Stock | |
| Lear Corp. | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 May 2024 | 1,337 | 1,337 | - | - | Restricted Stock Units | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 May 2024 | 14,000 | 73,235 | - | - | Director Stock Option (Right to Buy) | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 22.95 per share. | 02 May 2024 | 14,000 | 19,728 (0%) | 0% | 23.0 | 321,300 | Common Stock |
| Berry Global Group Inc | Jonathan F. Foster | Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 58.38 per share. | 02 May 2024 | 5,504 | 14,224 (0%) | 0% | 58.4 | 321,324 | Common Stock |
| Five Point Holdings LLC - ... | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2024 | 26,490 | 120,810 (0%) | 0% | 0 | Class A common shares | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Purchase of securities on an exchange or from another person at price $ 58.49 per share. | 12 Feb 2024 | 1,000 | 5,728 (0%) | 0% | 58.5 | 58,490 | Common Stock |
| Moleculin Biotech Inc | P. Jonathan Foster | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 0.69 per share. | 26 Dec 2023 | 28,986 | 80,556 (0%) | 0% | 0.7 | 20,000 | Common Stock |
| Berry Global Group Inc | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2023 | 1,970 | 1,393 | - | - | Restricted Stock Units | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 25 Nov 2023 | 1,970 | 4,728 (0%) | 0% | - | Common Stock | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2023 | 2,823 | 87,235 | - | - | Director Stock Option (Right to Buy) | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Nov 2023 | 1,393 | 3,363 | - | - | Restricted Stock Units | |
| Volcon Inc | Jonathan P. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jul 2023 | 200,000 | 376,250 | - | - | Stock Option | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 259,688 | 1,090,626 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Jun 2023 | 150,000 | 830,938 | - | - | Stock option (right to buy) | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 40,667 | 680,938 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 40,667 | 61,246 (0%) | 0% | - | Common Stock | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 12,500 | 23,623 (0%) | 0% | - | Common Stock | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2023 | 12,500 | 721,605 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share. | 16 Jun 2023 | 9,676 | 51,570 (0%) | 0% | 0.6 | 5,515 | Common Stock |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 0.57 per share. | 16 Jun 2023 | 3,044 | 20,579 (0%) | 0% | 0.6 | 1,735 | Common Stock |
| Lear Corp. | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 May 2023 | 1,419 | 1,419 | - | - | Restricted Stock Units | |
| Lear Corp. | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 1,317 | 0 | - | - | Restricted Stock Units | |
| Lear Corp. | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 May 2023 | 1,317 | 10,857 (0%) | 0% | 0 | Common Stock | |
| Masonite International Corp | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 May 2023 | 1,121 | 10,894 (0%) | 0% | 0 | Common Shares | |
| Lear Corp. | Jonathan Foster F. | Director | Purchase of securities on an exchange or from another person at price $ 138.11 per share. | 29 Mar 2023 | 61 | 11,026 (0%) | 0% | 138.1 | 8,425 | Common Stock |
| Lear Corp. | F. Foster Jonathan | Director | Purchase of securities on an exchange or from another person at price $ 136.74 per share. | 29 Mar 2023 | 54 | 10,965 (0%) | 0% | 136.7 | 7,384 | Common Stock |
| Lear Corp. | Foster Jonathan F. | Director | Purchase of securities on an exchange or from another person at price $ 139.54 per share. | 29 Mar 2023 | 52 | 10,911 (0%) | 0% | 139.5 | 7,256 | Common Stock |
| Five Point Holdings LLC - ... | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2023 | 35,874 | 94,320 (0%) | 0% | 0 | Class A common shares | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2022 | 3,415 | 84,412 | - | - | Director Stock Option (Right to Buy) | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Nov 2022 | 1,970 | 3,061 | - | - | Restricted Stock Units | |
| Volcon Inc | Jonathan P. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jul 2022 | 101,250 | 176,250 | - | - | Stock Option | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2022 | 162,667 | 734,105 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 Jun 2022 | 155,000 | 571,438 | - | - | Stock option (right to buy) | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 12,500 | 14,167 (0%) | 0% | - | Common Stock | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Jun 2022 | 12,500 | 416,438 | - | - | Restricted Stock Units | |
| Moleculin Biotech Inc | Jonathan P. Foster | Chief Financial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 1.33 per share. | 16 Jun 2022 | 3,044 | 11,123 (0%) | 0% | 1.3 | 4,049 | Common Stock |
| Lear Corp. | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2022 | 1,317 | 1,317 | - | - | Restricted Stock Units | |
| Lear Corp. | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2022 | 875 | 0 | - | - | Restricted Stock Units | |
| Lear Corp. | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 19 May 2022 | 875 | 9,309 (0%) | 0% | 0 | Common Stock | |
| Masonite International Corp | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 May 2022 | 1,191 | 9,773 (0%) | 0% | 0 | Common Shares | |
| Five Point Holdings LLC - ... | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Mar 2022 | 12,882 | 58,446 (0%) | 0% | 0 | Class A common shares | |
| Lear Corp. | Jonathan F. Foster | Director | Purchase of securities on an exchange or from another person at price $ 123.41 per share. | 29 Dec 2021 | 59 | 9,540 (0%) | 0% | 123.4 | 7,281 | Common Stock |
| Lear Corp. | Jonathan F. Foster | Director | Purchase of securities on an exchange or from another person at price $ 136.51 per share. | 29 Dec 2021 | 53 | 9,481 (0%) | 0% | 136.5 | 7,235 | Common Stock |
| Lear Corp. | Jonathan F. Foster | Director | Purchase of securities on an exchange or from another person at price $ 134.92 per share. | 29 Dec 2021 | 53 | 9,428 (0%) | 0% | 134.9 | 7,151 | Common Stock |
| Lear Corp. | Jonathan F. Foster | Director | Purchase of securities on an exchange or from another person at price $ 143.14 per share. | 29 Dec 2021 | 37 | 9,375 (0%) | 0% | 143.1 | 5,296 | Common Stock |
| Lear Corp. | Jonathan F. Foster | Director | Purchase of securities on an exchange or from another person at price $ 179.00 per share. | 29 Dec 2021 | 29 | 9,338 (0%) | 0% | 179 | 5,191 | Common Stock |
| Berry Global Group Inc | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 3,497 | 80,997 | - | - | Director Stock Option (Right to Buy) | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Nov 2021 | 1,091 | 2,758 | - | - | Restricted Stock Units | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2021 | 1,667 | 0 | - | - | Restricted Stock Units | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2021 | 1,667 | 1,667 (0%) | 0% | - | Common Stock | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2021 | 1,091 | 1,970 | - | - | Restricted Stock Units | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 23 Nov 2021 | 1,091 | 2,758 (0%) | 0% | - | Common Stock | |
| Moleculin Biotech Inc | Jonathan P. Foster | Exec. Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 108,770 | 378,938 | - | - | Stock option (right to buy) | |
| Moleculin Biotech Inc | Jonathan P. Foster | Exec. Vice President and CFO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 50,000 | 428,938 | - | - | Restricted Stock Units | |
| Lear Corp. | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 1,508 | 0 | - | - | Restricted Stock Units | |
| Lear Corp. | Jonathan F. Foster | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 20 May 2021 | 1,508 | 8,434 (0%) | 0% | 0 | Common Stock | |
| Lear Corp. | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2021 | 875 | 875 | - | - | Restricted Stock Units | |
| Masonite International Corp | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2021 | 855 | 8,582 (0%) | 0% | 0 | Common Shares | |
| Lear Corp. | Jonathan F. Foster | Director | Sale of securities on an exchange or to another person at price $ 187.82 per share. | 11 May 2021 | 2,700 | 6,926 (0%) | 0% | 187.8 | 507,105 | Common Stock |
| Masonite International Corp | Jonathan F. Foster | Director | Sale of securities on an exchange or to another person at price $ 127.22 per share. | 07 May 2021 | 2,300 | 7,727 (0%) | 0% | 127.2 | 292,606 | Common Shares |
| Five Point Holdings LLC - ... | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Feb 2021 | 12,638 | 44,839 (0%) | 0% | 0 | Class A common shares | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2020 | 5,000 | 77,500 | - | - | Director Stock Option (Right to Buy) | |
| Berry Global Group Inc | Jonathan F. Foster | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Nov 2020 | 1,667 | 1,667 | - | - | Restricted Stock Units | |
| Masonite International Corp | Jonathan F. Foster | Director | Sale of securities on an exchange or to another person at price $ 95.20 per share. | 17 Nov 2020 | 4,000 | 10,027 (0%) | 0% | 95.2 | 380,800 | Common Shares |